Pneomococcal VaccineThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

1722 records returned

FDA Advisory Committee Finds Data Support The Safety And Effectiveness Of Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal DiseasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pfizer Inc (NYSE:PFE) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee voted 10 to 1 that the data presented support the safety and effectiveness of its 13-valent pneumococcal conjugate candidate vaccine, Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]), for the prevention of invasive pneumococcal disease in infants and young children. (Source: Immune System / Vaccines News From Medical News Today)
Source: Immune System / Vaccines News From Medical News Today - November 20, 2009 Category: Allergy & Immunology Tags: Immune System / vaccines Source Type: news

FDA Panel Recommends Prevnar 13 Vaccine for ApprovalEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
An advisory committee voted 10 to 1 (with 1 abstention) to approve Pfizer's request for licensure of Prevnar 13 to immunize infants and children against invasive pneumococcal disease. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 19, 2009 Category: Consumer Health News Tags: Infectious Diseases Source Type: news

Swine Flu Deception and Disinformation ExposedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion - a recombinant strain produced from Bird Flu live viruses and a seasonal or Swine Flu strain can create a virus with morbidity (high widespread death rate).Last August, an international microbiologist in California, Joseph Moshe, called anti-vaccination activist Dr. A. True Ott, warning him of a bioweapon at Baxter's facilities in Ukraine that could be used to create a pandemic. Dr. Ott divulged this on Deagle's radio show after Moshe was forcefully apprehended.The Ukrainian IncidentUp until the 29th of October, there were only two non-lethal swine flu cases reported within Ukraine's 46 million population. Very...
Source: NaturalNews.com - November 19, 2009 Category: Consumer Health Advice Source Type: news

FDA Panel Votes in Favor of New Strep Pneumoniae VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BETHESDA, Md. (MedPage Today) -- A Food and Drug Administration (FDA) advisory panel has voted to recommend approval of an updated version of the Streptococcus pneumoniae vaccine Prevnar. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - November 18, 2009 Category: Geriatrics Source Type: news

Swine flu vaccine uptakeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Several newspapers have reported that pregnant women and other vulnerable people are refusing to have the swine flu vaccine. The Times reported that a poll of GPs found that only 46% of people who were offered the vaccine have accepted it, and one doctor estimated that only 5% of pregnant women have had it. The news reports are based on a “snapshot” survey of 107 GPs. The survey asked how likely they were to hit the government’s target of vaccinating at least half of their patients who are under 65 and in high-risk groups this winter. GPs were also asked to estimate how many of the people who were offered the vacci...
Source: NHS News Feed - November 18, 2009 Category: Consumer Health News Tags: Swine flu Source Type: news

Pneumococcal conjugate vaccines effective at preventing child deaths, study suggestsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A new study concludes that pneumococcal conjugate vaccines (PCV), already known to prevent invasive pneumococcal disease (IPD) and X-ray defined pneumonia, were also effective against child deaths. According to the review, 80 percent of children were less likely to develop vaccine-type IPD, 58 percent all-serotype IPD, and 27 percent x-ray defined pneumonia than children who did not receive the vaccine. Eleven percent of child deaths were also prevented. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 18, 2009 Category: Science Source Type: news

Elimination of False Positive Results in a Luminex assay for Pneumococcal Antibodies.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We describe here methods that eliminated the false positive reactivity of both groups. PMID: 19923569 [PubMed - as supplied by publisher] (Source: Clinical and Vaccine Immunology)
Source: Clinical and Vaccine Immunology - November 18, 2009 Category: Allergy & Immunology Authors: Pickering JW, Larson MT, Martins TB, Copple SS, Hill HR Tags: Clin vaccine Immunol Source Type: journals

FDA Panel to Vote on Updated Strep pneumoniae VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
WASHINGTON (MedPage Today) -- A Food and Drug Administration (FDA) advisory panel will decide Wednesday whether to recommend approval of a new version of the popular Streptococcus pneumoniae children's vaccine Prevnar. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - November 17, 2009 Category: Geriatrics Source Type: news

Ask the doctor: I often get pneumonia, so should I have a jab?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Dr Martin Scurr has been treating patients for more than 30 years and is one of the country's leading GPs. Here he tackles pneumonia and cat allergies. (Source: the Mail online | Health)
Source: the Mail online | Health - November 17, 2009 Category: Consumer Health News Source Type: news

H1N1 "super flu" plague in Ukraine spark concern, conspiracy theories about originsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(NaturalNews) Here's what we know with some degree of certainty about the H1N1 virus in Ukraine right now: nearly 300 people have died from the viral strain, and over 65,000 people have been hospitalized (the actual numbers are increasing by the hour). The virus appears to be either a highly aggressive mutation of the globally-circulating H1N1 strain, or a combination of three different influenza strains now circulating in Ukraine. Some observers suspect this new "super flu" might be labeled viral hemorrhagic pneumonia (meaning it destroys lung tissue until your lungs bleed so much that you drown in your own fluid), but th...
Source: NaturalNews.com - November 16, 2009 Category: Consumer Health Advice Source Type: news

Pneumococcal vaccines: search for an optimal agentEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 15, 2009 Category: Health Management Tags: Short communication Source Type: journals

Should my asthmatic child get the H1N1 vaccine?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We’ve received a lot of questions from parents who want to know if the H1N1 vaccine is safe for children with asthma and what complications could result if an asthmatic child is infected with H1N1. We consulted with Children’s Hospital Boston’s associate chief of general pediatrics, Joanne Cox, MD, and reviewed the latest reports from the Centers for Disease Control and Prevention to bring you the most recent information. Is the H1N1 vaccine safe for my child with asthma? Children with asthma or a reactive airways disease should receive the H1N1 vaccine shot, not the H1N1 nasal spray vaccine. The nasal-sp...
Source: Thrive, Children's Hospital Boston - November 13, 2009 Category: Pediatrics Authors: Children's Hospital Boston staff Tags: All posts H1N1 (swine flu) asthma asthma and h1n1 Flu vaccine swine flu vaccine Source Type: organizations

The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cellsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
It was recently shown that bacterial thymus-independent (TI) antigens confer long-lasting immunity and generate memory B lymphocytes. However, reactivation of TI memory B cells is repressed in immunocompetent mice, thus raising the issue of the mechanism whereby TI vaccines confer immune protection. Here, we propose an explanation to this apparent paradox by showing that a Streptococcus pneumoniae capsular polysaccharide (PS) generates long-lived bone marrow (BM) plasma cells which frequency can be increased by CpG oligodeoxynucleotides (ODNs). The adjuvant effect of CpG ODNs on the PS3 Ab response is directly targeted to ...
Source: Blood - November 12, 2009 Category: Hematology Authors: Taillardet, M., Haffar, G., Mondiere, P., Asensio, M.-J., Gheit, H., Burdin, N., Defrance, T., Genestier, L. Tags: Immunobiology Source Type: journals

Pediatric parapneumonic pleural effusion: Epidemiology, clinical characteristics, and microbiological diagnosisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In recent years an increase in the incidence and severity of parapneumonic pleural effusion (PPE) in pediatric populations has been observed. Streptococcus pneumoniae remains the main causal agent. New molecular and antigen techniques have increased the microbiological diagnosis of this pathology.To describe the epidemiology and clinical characteristics of PPE in our population.Prospective study of patients under the age of 18 years admitted for PPE in a tertiary-care pediatric hospital in Barcelona (Spain) between September 2003 and December 2006.One hundred ninety cases of PPE were diagnosed. The annual incidence of PPE ...
Source: Pediatric Pulmonology - November 12, 2009 Category: Respiratory Medicine Authors: Susanna Hernández-Bou, Juan José García-García, Cristina Esteva, Amadeu Gené, Carles Luaces, Carmen Muñoz Almagro Source Type: journals

Laboratory diagnosis of specific antibody deficiency to pneumococcal capsular polysaccharide antigens by multiplexed bead assay.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We evaluated a multiplexed bead-based assay (xMAP(R) Pneumococcal Immunity assay from Luminex) for the simultaneous determination of antibodies against 14 capsular polysaccharides. Post-vaccination (Pneumovax(R)) antibody concentrations were measured in 35 healthy children, 40 healthy adults, 99 consecutive patients with increased susceptibility to respiratory infection, and 24 patients with a deficient anti-polysaccharide antibody response. The serotype-specific lower 5th percentile (cutoff) value for the post-immunization antibody concentration was determined in healthy individuals. Eleven of 99 patients (11%) failed...
Source: Clinical Immunology - November 12, 2009 Category: Allergy & Immunology Authors: Borgers H, Moens L, Picard C, Jeurissen A, Raes M, Sauer K, Proesmans M, De Boeck K, Casanova JL, Meyts I, Bossuyt X Tags: Clin Immunol Source Type: journals

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine at 12 to 15 months of age in healthy UK infants primed with two doses of one of three monovalent meningococcal serogroup C vaccines.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The kinetics of antibody persistence following the administration of a combination meningococcal serogroup C and Haemophilus influenzae type b (Hib) conjugate vaccine (Menitorix) in the second year of life in children primed with two doses of one of three monovalent meningococcal serogroup C (MCC) vaccines was investigated. Study subjects were either administered Menitorix at 12 to 15 months of age followed by the 7-valent pneumococcal conjugate (PCV7) and measles, mumps and rubella (MMR) vaccine 4 to 6 weeks later or all three vaccines concomitantly at 12 to 15 months of age. Blood samples were collected before and 1,...
Source: Clinical and Vaccine Immunology - November 11, 2009 Category: Allergy & Immunology Authors: Borrow R, Andrews N, Findlow H, Waight P, Southern J, Crowley-Luke A, Stapley L, England A, Findlow J, Miller E Tags: Clin vaccine Immunol Source Type: journals

Comparison of three antigenic extracts of Eurotium amstelodami in farmer's lung disease serological diagnosis.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In conclusion, serological diagnosis of FLD by ELISA was improved by the adjunction of ascospore antigen. PMID: 19906892 [PubMed - as supplied by publisher] (Source: Clinical and Vaccine Immunology)
Source: Clinical and Vaccine Immunology - November 11, 2009 Category: Allergy & Immunology Authors: Roussel S, Reboux G, Rognon B, Monod M, Grenouillet F, Quadroni M, Fellrath JM, Aubert JD, Dalphin JC, Millon L Tags: Clin vaccine Immunol Source Type: journals

Susceptibility of pneumococci causing meningitis in Spain and prevalence among such isolates of serotypes contained in the 7-valent pneumococcal conjugate vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Journal of Antimicrobial Chemotherapy)
Source: Journal of Antimicrobial Chemotherapy - November 10, 2009 Category: Microbiology Authors: Fenoll, A., Gimenez, M.-J., Vicioso, M.-D., Granizo, J.-J., Robledo, O., Aguilar, L. Tags: Research letters Source Type: journals

Letter to Providers Promoting PPSV for AdultsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Pneumococcal infections have been identified as an important complication in severe and fatal cases of 2009 H1N1 influenza virus infection. CDC has written a letter to providers urging them to make sure all their adult patients with indications have received the pneumococcal polysaccharide vaccine. (Source: CDC Swine Flu Updates)
Source: CDC Swine Flu Updates - November 10, 2009 Category: Infectious Diseases Source Type: organizations

Also In Global Health News: Nutritionally-Enhanced Products; Health Care In India; Cell Phones As Microscopes; GSK Pneumonia Vaccine; Men Fighting HIVEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
News Outlets Examine Nutritionally-Enhanced Products The East African examines the recent launch of a $21.25 million research project, at the International Sweet Potato Centre in Uganda, that aims to develop "nutritionally enhanced sweet potatoes â€¦ to reduce health problems related to vitamin A deficiency and improve food security in sub-Saharan Africa. (Source: Nutrition/Agriculture News From Medical News Today)
Source: Nutrition/Agriculture News From Medical News Today - November 10, 2009 Category: Nutrition Tags: Nutrition / Diet Source Type: news

Also In Global Health News: Nutritionally-Enhanced Products; Health Care In India; Cell Phones As Microscopes; GSK Pneumonia Vaccine; Men Fighting HIVEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
News Outlets Examine Nutritionally-Enhanced Products The East African examines the recent launch of a $21.25 million research project, at the International Sweet Potato Centre in Uganda, that aims to develop "nutritionally enhanced sweet potatoes â€¦ to reduce health problems related to vitamin A deficiency and improve food security in sub-Saharan Africa. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 10, 2009 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Uptake of Adult Vaccination Varies Widely in Urban AreasEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
There are wide variations in the uptake of pneumococcal polysaccharide vaccine and influenza vaccine in adults in urban areas, and physicians' practice characteristics influence the likelihood of their patients getting vaccinated, according to a study in the November/December Annals of Family Medicine. (Source: Modern Medicine)
Source: Modern Medicine - November 10, 2009 Category: Journals (General) Source Type: info

WHO Grants Prequalification for Global Use to GSK's 10-Valent Synflorix™ VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The World Health Organization (WHO) has awarded prequalification for global use of Synflorix™, GlaxoSmithKline Biologicals' pneumococcal conjugate vaccine. This is the first prequalification for a vaccine against pneumococcal disease, which is a life-threatening disease affecting many children under five in developing countries. (Source: World Pharma News)
Source: World Pharma News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Amelioration of pneumonia with Streptococcus pneumoniae infection by inoculation with a vaccine against highly pathogenic avian influenza virus in a non-human primate mixed infection modelEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions Vaccination against HPAIV reduces pneumonia caused by bacterial superinfection and may improve prognosis of HPAIV-infected patients. (Source: Journal of Medical Primatology)
Source: Journal of Medical Primatology - November 9, 2009 Category: Research Authors: Taichiro Miyake, Kosuke Soda, Yasushi Itoh, Yoshihiro Sakoda, Hirohito Ishigaki, Tomoya Nagata, Hideaki Ishida, Misako Nakayama, Hiroichi Ozaki, Hideaki Tsuchiya, Ryuzo Torii, Hiroshi Kida, Kazumasa Ogasawara Source Type: journals

H1N1: What are the Real Risks?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Travelling during a global pandemic is a risky business! I just got back from a trip to another province of Canada, a four hour flight away. While Ontario is handing out Swine Flu vaccine to the "priority groups" - small children, seniors and health-care workers, BC is facing a shortage and Alberta is dealing with bioethics issues arising from the public outcry over vaccination of the Calgary Flames, and a debate over whether firefighters are a high-risk group. One of the participants of a meeting I attended refused to shake anyone's hand for fear of getting sick, and last week I heard from a friend that children in her ne...
Source: About.com Biotech Biomedical - November 8, 2009 Category: Biotechnology Source Type: consumer

Dutch Pull Pfizer Vaccine Batch After Infants DieEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Dutch authorities say they have banned use of a batch of Pfizer Inc's (PFE.N) Prevenar, or Prevnar, after three infants died within two weeks of receiving the anti-infection vaccination. Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2009 Category: Consumer Health News Tags: Public Health & Prevention Source Type: news

CDC Health Alert Network (HAN) Info Service Message: 2009 H1N1 Pandemic Update: Pneumococcal Vaccination Recommended to Help Prevent Secondary InfectionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The 2009 pandemic H1N1 influenza virus continues to be the dominant influenza virus in circulation in the U.S. The benefit of antiviral treatment is greatest when it is initiated as early as possible in the clinical course. (Source: CDC Swine Flu Updates)
Source: CDC Swine Flu Updates - November 6, 2009 Category: Infectious Diseases Source Type: organizations

World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Endorsement is first for vaccine for pneumococcal disease - a life-threatening disease affecting many children; follows first-ever World Pneumonia Day (Source: GSK news)
Source: GSK news - November 6, 2009 Category: Pharmaceuticals Source Type: organizations

Spread of swine flu virus could be stallingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Slight decrease in GP consultation rates for flu-like illness seen this weekRelated items from OnMedicaGuidance on pandemic flu issued to GP practicesFlu jabs recommended for those aged over 60First death from swine flu in the UKPneumococcal vaccine does not protect elderly against pneumoniaScotland will not be fully vaccinated against swine flu for 18 months (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 6, 2009 Category: UK Health Source Type: news

Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The 27th annual meeting of the European Society for Paediatric Infectious Diseases (ESPID), held in Brussels, Belgium, addressed serious bacterial infections. The scientific program included international experts who provided insights into and discussions on the epidemiology, diagnosis, prevention, treatment, and clinical presentation of important pediatric infectious diseases. This conference report offers highlights of presentations addressing pneumococcal disease and pneumococcal conjugate vaccines. PMID: 19883868 [PubMed - in process] (Source: Vaccine)
Source: Vaccine - November 5, 2009 Category: Allergy & Immunology Authors: Adam D Tags: vaccine Source Type: journals

Dutch pull Pfizer vaccine batch after infants dieEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
AMSTERDAM (Reuters) - Dutch authorities say they have banned use of a batch of Pfizer's Prevenar, or Prevnar, after three infants died within two weeks of receiving the anti-infection vaccination. (Source: Reuters: Health)
Source: Reuters: Health - November 5, 2009 Category: Consumer Health News Tags: healthNews Source Type: news

Features of bacterial growth and polysaccharide production of Streptococcus pneumoniae serotype 14Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The effect of several cultivation conditions on the kinetics of bacterial growth and polysaccharide production of S. pneumoniae serotype 14 was studied. The presence in the supernatant of serotype specific capsular polysaccharide (CPS) during growth was followed by size exclusion HPLC and in parallel confirmed by a specific latex reagent. Agitation level did not affect the production behaviour, whereas pH maintenance above 6 strongly enhanced both growth and CPS production throughout the cultivation period in flasks. Production of high molecular weight polysaccharide was found to be largest between 5 to 6 hr cultivation, a...
Source: Biotechnology and Applied Biochemistry - November 5, 2009 Category: Biochemistry Authors: H Massaldi, M Inés Bessio, N Suárez, E Texeira, S Rossi, F Ferreira Source Type: journals

Impairment of T Cell Immunity by the Respiratory Syncytial Virus: Targeting Virulence Mechanisms for Therapy and Prophylaxis.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Worldwide, Respiratory Syncytial Virus (RSV) causes severe bronchiolitis and pneumonia in children, the elderly and immuno-compromised individuals. Moreover, RSV is the mayor cause of infant hospitalization due to lower respiratory infection, regardless socioeconomic status. Accumulating data support the notion that immune responses elicited against naturally acquired RSV infections are non-lasting and inappropriate for efficient virus clearance. Although there is consensus over the capacity of RSV to impair the development of an effective and protective adaptive immune response, very little is known about specific vir...
Source: Current Medicinal Chemistry - November 5, 2009 Category: Chemistry Authors: González PA, Bueno SM, Riedel CA, Kalergis AM Tags: Curr Med Chem Source Type: journals

News Outlets Examine First World Pneumonia DayEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
To mark the first World Pneumonia Day, Inter Press Service examines how vaccines and other strategies can be used to combat the disease, which kills more children under age 5 each year "than measles, malaria, and AIDS combined, according to the Global Coalition against Child Pneumonia. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 4, 2009 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Evaluation of pneumococcal polysaccharide immunoassays using 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The history of pneumococcal polysaccharide ELISA is characterized by a continuous search for increased specificity. A third generation ELISA using 22F polysaccharide inhibition has increased assay specificity particularly at low antibody concentrations. In the present work, various 22F/non-22F ELISA comparisons were made, involving three different laboratories, including a WHO reference laboratory, and using sera from subjects from different geographic areas immunized with different pneumococcal conjugate vaccines, including the licensed 7-valent Prevenar(TM) and 10-valent Synflorix(TM). All comparisons led to the same...
Source: Clinical and Vaccine Immunology - November 4, 2009 Category: Allergy & Immunology Authors: Poolman JT, Frasch CE, Käyhty H, Lestrate P, Madhi SA, Henckaerts I Tags: Clin vaccine Immunol Source Type: journals

ProQuadEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Approval Letter and Approved Final Draft Labeling for Merck's Efficacy Supplement for Measles, Mumps, Rubella, and Varicella Vaccine, Live, (ProQuad®), to include concomitant administration with hepatitis A vaccine (VAQTA®) and/or pneumococcal conjugate vaccine (Prevnar®), use of ProQuad® in children 15 months to 12 years of age if a second dose of measles, mumps, rubella, and varicella is needed, additional safety data after a first or second dose of ProQuad®, and to comply with the Physician’s Labeling Rule format, have been issued. (Source: What's New at CBER)
Source: What's New at CBER - November 3, 2009 Category: Biomedical Science Source Type: organizations

HEALTH: Vaccines, Antibiotics Could Slash Pneumonia DeathsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
UNITED NATIONS, Nov 2 (IPS) - Seven-month-old Marta lived in the central highlands of Guatemala when she came down with a high fever and rapid, shallow breathing. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 3, 2009 Category: Global & Universal Source Type: news

Nigeria: FG to Acquire Pneumonia Vaccine By 2011 - HongEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Federal Government will by 2011 acquire the much sought pneumonia vaccine to curb the spread of pneumonia which has been identified as one of the biggest causes of child death in the world. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 3, 2009 Category: African Health Source Type: news

Pfizer Quarantines Prevnar Batch After Infant DeathsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Dutch authorities say they have banned use of a batch of Pfizer Inc's Prevenar, or Prevnar in the U.S. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - November 2, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info

Pneumonia Can Be Prevented - Vaccines Can HelpEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Source: Centers for Disease Control and Prevention Related MedlinePlus Topic: Pneumonia (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 2, 2009 Category: Consumer Health News Source Type: consumer

Pneumonia: Vaccination Essential To Prevent World's Leading Child KillerEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Marking the first international World Pneumonia Day on 2 November, the GAVI Alliance plans to immunise 130 million children in poor countries against pneumonia, the world's leading child killer. Pneumonia, a severe inflammation of the lungs usually caused by infection, is responsible for one in four child deaths, more than HIV/AIDs, malaria and measles combined. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 2, 2009 Category: Consumer Health News Tags: Respiratory / Asthma Source Type: news

Pneumonia vaccine could save money in flu pandemicEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CHICAGO (Reuters) - A more protective form of Pfizer's vaccine for pneumococcal disease would be highly effective at preventing deaths from pandemic influenza, independent researchers and the company reported over the weekend. (Source: Reuters: Health)
Source: Reuters: Health - November 2, 2009 Category: Consumer Health News Tags: healthNews Source Type: news

Pneumonia vaccine plans will protect 130 million childrenEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Global alliance proposes $4 billion plan to save millions of livesRelated items from OnMedicaWHO to help in fight against a global flu pandemicSwine flu rate doubled last week, according to new figuresGPs to spearhead swine flu mass vaccinationParent support vital on flu jabsMore aggressive superbug screening of healthcare workers needed (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 2, 2009 Category: UK Health Source Type: news

Otitis media: viruses, bacteria, biofilms and vaccines.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Otitis media typically presents as either acute otitis media (AOM), with symptoms including fever, otalgia, otorrhoea or irritability and short duration; or as otitis media with effusion (OME), which is often asymptomatic and characterised by accumulation of fluid in the middle ear. Diagnostic certainty of otitis media is challenging, given the young age of patients and variability of symptoms. Otitis media predominantly occurs as coincident to viral upper respiratory tract infections and/or bacterial infections. Common viruses that cause upper respiratory tract infection are frequently associated with AOM and new-onse...
Source: Med J Aust - November 2, 2009 Category: Journals (General) Authors: Massa HM, Cripps AW, Lehmann D Tags: Med J Aust Source Type: journals

Vaccines Protect the Whole CommunityEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The decision to get vaccinated against a disease such as H1N1 is a personal one. I've noticed this reflected in the way people talk about the decision -- whether they are in the higher risk groups, whether they mind being ill etc. Yet it is worth bearing in mind that your decision whether or not to get vaccinated may affect many more people than just you. You are also affecting everyone you could potentially pass the virus on to. And with people being contagious both before symptoms appear and after they disappear, there is a high likelihood that you will pass it on to many others without realizing it if you are not vaccin...
Source: About.com Addictions - November 1, 2009 Category: Addiction Source Type: consumer

Clinical inquiries. Which asthma patients should get the pneumococcal vaccine?Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PMID: 19891942 [PubMed - in process] (Source: The Journal of Family Practice)
Source: The Journal of Family Practice - November 1, 2009 Category: Practice Management Authors: Harris JB, Edgerton L, Stafford K Tags: J Fam Pract Source Type: journals

Understanding adult vaccination in urban, lower-socioeconomic settings: influence of physician and prevention systems.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: Vaccination rates vary widely in urban settings and are associated with practice characteristics such as time spent with patients and, for influenza vaccine, use of standing orders. PMID: 19901313 [PubMed - in process] (Source: Annals of Family Medicine)
Source: Annals of Family Medicine - November 1, 2009 Category: Primary Care Authors: Zimmerman RK, Nowalk MP, Tabbarah M, Hart JA, Fox DE, Raymund M, Tags: Ann Fam Med Source Type: journals

Aid group seeks $4 billion for life-saving vaccinesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
GENEVA (Reuters) - A vaccine aid group said on Friday it was seeking $4 billion to protect as many as 130 million of the world's poorest children against diarrhea and pneumonia. (Source: Reuters: Health)
Source: Reuters: Health - October 30, 2009 Category: Consumer Health News Tags: healthNews Source Type: news